Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36301437)

  • 1. Barriers for Participation in the Danish Colorectal Cancer Screening Program: a Qualitative Study.
    Phillipsen S; Weltz LK; Dressler J; Nielsen MK; Rasmussen M; Jorgensen LN; Johnsen AT
    J Gastrointest Cancer; 2023 Sep; 54(3):873-881. PubMed ID: 36301437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, Attitudes, and Beliefs About Colorectal Cancer Screening in Puerto Rico.
    Colón-López V; Valencia-Torres IM; Ríos EI; Llavona J; Vélez-Álamo C; Fernández ME
    J Cancer Educ; 2023 Apr; 38(2):552-561. PubMed ID: 35359256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in attitudes impeding colorectal cancer screening.
    Ritvo P; Myers RE; Paszat L; Serenity M; Perez DF; Rabeneck L
    BMC Public Health; 2013 May; 13():500. PubMed ID: 23706029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
    Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
    Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To do or not to do - a survey study on factors associated with participating in the Danish screening program for colorectal cancer.
    Nielsen JB; Berg-Beckhoff G; Leppin A
    BMC Health Serv Res; 2021 Jan; 21(1):43. PubMed ID: 33413310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for participation and non-participation in colorectal cancer screening.
    Berg-Beckhoff G; Leppin A; Nielsen JB
    Public Health; 2022 Apr; 205():83-89. PubMed ID: 35248951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
    Toft EL; Kaae SE; Malmqvist J; Brodersen J
    Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors affecting patient adherence to publicly funded colorectal cancer screening programmes: a systematic review.
    Dressler J; Johnsen AT; Madsen LJ; Rasmussen M; Jorgensen LN
    Public Health; 2021 Jan; 190():67-74. PubMed ID: 33360029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stitch in time saves nine: Perceptions about colorectal cancer screening after a non-cancer colonoscopy result. Qualitative study.
    Kirkegaard P; Edwards A; Andersen B
    Patient Educ Couns; 2019 Jul; 102(7):1373-1379. PubMed ID: 30853142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer patients can be advocates for colorectal cancer screening for their siblings: A study on siblings' perspectives.
    Tan KK; Lim TZ; Chew E; Chow WM; Koh GC
    Psychooncology; 2020 Dec; 29(12):2028-2032. PubMed ID: 32715510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in diagnostic activity in general practice and findings for individuals invited to the danish screening programme for colorectal cancer: a population-based cohort study.
    Juul JS; Andersen B; Laurberg S; Carlsen AH; Olesen F; Vedsted P
    Scand J Prim Health Care; 2018 Sep; 36(3):281-290. PubMed ID: 29929415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why do some participants in colorectal cancer screening choose not to undergo colonoscopy following a positive test result? A qualitative study.
    Bie AKL; Brodersen J
    Scand J Prim Health Care; 2018 Sep; 36(3):262-271. PubMed ID: 30238859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers of and facilitators to physician recommendation of colorectal cancer screening.
    Guerra CE; Schwartz JS; Armstrong K; Brown JS; Halbert CH; Shea JA
    J Gen Intern Med; 2007 Dec; 22(12):1681-8. PubMed ID: 17939007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colon Cancer among Older Saudis: Awareness of Risk Factors and Early Signs, and Perceived Barriers to Screening.
    Galal YS; Amin TT; Alarfaj AK; Almulhim AA; Aljughaiman AA; Almulla AK; Abdelhai RA
    Asian Pac J Cancer Prev; 2016; 17(4):1837-46. PubMed ID: 27221862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions about cancer and barriers towards cancer screening among ethnic minority women in a deprived area in Denmark - a qualitative study.
    Tatari CR; Andersen B; Brogaard T; Badre-Esfahani SK; Jaafar N; Kirkegaard P
    BMC Public Health; 2020 Jun; 20(1):921. PubMed ID: 32532227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening participation among citizens not recommended to be screened: a cohort study.
    Larsen PT; Jørgensen SF; Njor SH
    BMC Gastroenterol; 2022 May; 22(1):256. PubMed ID: 35596148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filipinos' attitudes, barriers, and enablers on colorectal cancer screening: Insights from a qualitative research study.
    Khalil C; Chaplin A; Esmundo S; Crochetiere A; Almario CV
    Cancer Treat Res Commun; 2022; 33():100657. PubMed ID: 36410092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
    Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
    Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.